RDHL
RedHill Biopharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.57
−4.13%Margins
Gross margin
100.0%
EBITDA margin
-2675.5%
EBIT margin
-2765.4%
Net margin
-150.0%
FCF margin
-3376.2%
9.7%
Return on equity
-2.3%
Return on assets
188.4%
Return on invested capital
0.02x
Asset turnover
-$9.7M
Cash from operations
$0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025